Allosteric Antagonists
Allosteric Antagonist is a type of allosteric modulator that binds to a site distinct from the orthosteric site of a receptor and induces a conformational change that reduces or inhibits the receptor's activity in response to its endogenous agonist.
103
Publications
5.6K
Citations
731
Authors
203
Institutions
Publications per year
2017–2026
26
Variants
Allosteric Inhibitors
Parents
103
Richard H. Porter, Georg Jaeschke, Will Spooren et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 314 citations · Full text
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Yi Zheng, Ling Qin, Natalia V. Ortiz Zacarı́as et al. · Nature · 2016 · 296 citations · Full text
1–5 of 103
731
6
h-index
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 731
203
Novartis (Switzerland)
Basel, Switzerland
6 h-index
42 publications
3.4K citations
University of Bonn
Bonn, Germany
6 h-index
27 publications
1.4K citations
Vanderbilt University Medical Center
Nashville, United States
5 h-index
40 publications
1.2K citations

Vanderbilt University
Nashville, United States
5 h-index
8 publications
273 citations
Latvijas Organiskās Sintēzes Institūts
Riga, Latvia
4 h-index
10 publications
308 citations
Leiden University
Leiden, The Netherlands
4 h-index
28 publications
2.1K citations
Goethe University Frankfurt
Frankfurt am Main, Germany
4 h-index
11 publications
374 citations
MerLion Pharma (Germany)
Berlin, Germany
4 h-index
22 publications
536 citations
1–8 of 203
11 publications · 1.1K citations
11
h-index
9 publications · 351 citations
9
h-index
7 publications · 607 citations
7
h-index
7 publications · 163 citations
7
h-index
BJP · 4 publications · 230 citations
4
h-index
1–5